Ray Kurzweil - Jul 24, 2025 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Jul 24, 2025
Transactions value $
$0
Form type
4
Date filed
7/28/2025, 06:24 AM
Previous filing
Mar 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KURZWEIL RAY Director C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 2025-07-25 0001108501

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $0 +590 +4.88% $0.00 12.7K Jul 25, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Unit Options Exercise $0 -590 -100% $0.00 0 Jul 25, 2025 Common Stock 590 $0.00 Direct F1, F2
transaction UTHR Restricted Stock Unit Award $0 +650 $0.00 650 Jul 24, 2025 Common Stock 650 $0.00 Direct F2, F3, F4
transaction UTHR Stock Options Award $0 +1.83K $0.00 1.83K Jul 24, 2025 Common Stock 1.83K $306.41 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
F2 Not applicable as restricted stock units do not have an expiration date.
F3 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F4 Annual non-employee director award.